Inhibition of Cytokine-Induced Microvascular Arrest of Tumor Cells by Recombinant Endostatin Prevents Experimental Hepatic Melanoma Metastasis

Cancer Research

Volumn 64, Issue 1, 2004, Pages 304-310

  Mendoza, Lorea ^a   Valcárcel, María ^b   Carrascal, Teresa ^a   Egilegor, Eider ^a   Salado, Clarisa ^a   Sim, B Kim Lee ^c,d   Vidal Vanaclocha, Fernando ^a,b  

^a Pharmakine Ltd   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c ENTREMED INC   (United States)

^d Protein Potential   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOSTATIN; INTERLEUKIN 18; LUCIFERASE; RECOMBINANT ENDOSTATIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER; LIVER METASTASIS; MALE; MELANOMA; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TUMOR CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; ENDOSTATINS; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROCIRCULATION; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1642535552     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1829     Document Type: Article

References (31)

1. Weiss, L., Orr, F. W., and Honn, K. V. Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin. Exp. Metastasis, 7: 127-167, 1989.
2. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 19: 331-358, 1974.
3. Okahara, H., Yagita, H., Mikaye, K., and Okumura, K. Involvement of very late antigen-4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor a enhancement of experimental metastasis. Cancer Res., 54: 3233-3236, 1994.
4. Orr, F. W., Wang, H. W., Lafrenie, R. M., Scherbarth, S., and Nance, D. M. Interactions between cancer cells and the endothelium in metastasis. J. Pathol., 190: 310-329, 2000.
5. Vidal-Vanaclocha, F., Amézaga, C., Asumendi, A., Kaplanski, G., and Dinarello, C. A. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res., 54: 2667-2672, 1994.
6. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
7. Feldman, A. L., Tamarkin, L., Paciotti, G. F., Simpson, B. W., Linehan, W. M., Yang, J. C., et al. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin. Cancer Res., 6: 4628-4634, 2000.
8. Feldman, A. L., Alexander, H. R., Jr., Bartlett, D. L., Kranda, K. C., Miller, M. S., Costouros, N. G., Choyke, P. L., and Libutti, S. K. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann. Surg. Oncol., 8: 741-745, 2001.
9. Solaun, M. S., Mendoza, L., de Luca, M., Gutierrez, V., López, M-P., Olaso, E., Lee Sim, B. K., and Vidal-Vanaclocha, F. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium. Hepatology, 35: 1104-1116, 2002.
10. Liotta, L. A., and Stetler-Stevenson, W. G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51: 5054-5059, 1991.
11. Mendoza, L., Carrascal, T., De Luca, M., Fuentes, A. M., Salado, C., Blanco, J., and Vidal-Vanaclocha, F. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver. Hepatology, 34: 298-310, 2001.
12. Vidal-Vanaclocha, F., Fantuzzi, G., Mendoza, L., Fuentes, A., Anasagasti, M., Martín, J., and Dinarello, C. A. IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc. Natl. Acad. Sci. USA, 97: 734-739, 2000.
13. Kim, I., Moon, S. O., Kim, S. H., Kim, H. J., Koh, Y. S., and Koh, G. Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J. Biol. Chem., 276: 7614-7620, 2001.
14. Straume, O., and Akslen, L. A. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am. J. Pathol., 159: 223-235, 2001.
15. Sim, B. K., Fogler, W. E., Zhou, X. H., Liang, H., Madsen, J. W., Luu, K., et al. Zinc ligand-disrupted recombinant human endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile. Angiogenesis, 3: 41-51, 1999.
16. Rubio, N., Martinez-Villacampa, M., and Blanco, J. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker. Lab. Investig., 78: 1315-1325, 1998.
17. Vidal-Vanaclocha, F., Rocha, M., Asumendi, A., and Barbera-Guillem, E. Isolation and enrichment of two sublobular compartment-specific endothelial cell subpopulations from liver sinusoids. Hepatology, 18: 328-339, 1993.
18. Carrascal, T., Mendoza, L., Valcarcel, M., Salado, C., Egilegor, E., Tellería, N., Vidal-Vanaclocha, F., and Dinarello, C. A. Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res., 63: 491-497, 2003.
19. Claffey, K. P., and Robinson, G. S. Cancer regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Metastasis Rev., 15: 165-176, 1996.
20. Osaki, T., Peron, J. M., Cai, Q., Okamura, H., Robbins, P. D., Kurimoto, M., et al. IFN-γ-inducing factor/1L-18 administration mediates IFN-γ and IL-12-independent antitumor effects. J. Immunol., 160: 1742-1749, 1998.
21. Cao, R., Farnebo, J., Kurimoto, M., and Cao, Y. Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J., 13: 2195-2202, 1999.
22. Cho, D., Song, H., Kim, Y. M., Houh, D., Hur, D. Y., Park, H., et al. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res., 60: 2703-2709, 2000.
23. Park, C. C., Morel, J. C., Amin, M. A., Connors, M. A., Harlow, L. A., and Koch, A. E. Evidence of IL-18 as a novel angiogenic mediator. J. Immunol., 167: 1644-1653, 2001.
24. Fidler, I. J. Selection of successive tumour lines for metastasis. Nat. New Biol., 242: 148-149, 1973.
25. Anasagasti, M. J., Olaso, E., Calvo, F., Mendoza, L., Martin, J. J., Bidaurrazaga, J., and Vidal-Vanaclocha, F. Interleukin 1-dependent and -independent mouse melanoma metastases. J. Natl. Cancer Inst. (Bethesda), 89: 645-651, 1997.
26. Rehn, M., Veikkola, T., Kukk-Valdre, H., Nakamura, H., Ilmonen, M., Lombardo, C. R., et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA, 98: 1024-1029, 2001.
27. 1 integrins. Proc. Natl. Acad. Sci. USA, 100: 4766-4771, 2003.
28. 3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO, J., 18: 882-892, 1999.
29. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Investig., 95: 1789-1797, 1995.
30. Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijima, H., Tsuchida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N., and Nakamura, M. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br. J. Cancer, 77: 998-1002, 1998.
31. Li, Y., Wang, M. N., Li, H., King, K. D., Bassi, R., Sun, H., Santiago, A., Hooper, A. T., Bohlen, P., and Hicklin, D. J. Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J. Exp. Med., 195: 1575-1584, 2002.